Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer

Journal: Cancer Research

Published: 2020-09-01

DOI: 10.1158/0008-5472.can-19-3934

Affiliations: 8

Authors: 30

Go to article
Institutions Share
St. Jude Children's Research Hospital (St. Jude), United States of America (USA) 0.97
Hartwell Center for Bioinformatics and Biotechnology, St. Jude, United States of America (USA) 0.03